On June 19th, Gelunhui reported that Minsheng Healthcare (301507.SZ) recently stated during a meeting with institutional investors that in recent years, both 21Jinweta single products and new products have maintained growth in sales and profits, with new products growing at a faster rate.
民生健康(301507.SZ)：近年来21金维他单品和新产品均保持销量和利润的增长
In recent years, both 21Jinweita single products and new products of Minsheng Health (301507.SZ) have maintained growth in sales and profits.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.